TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 16:05 | 6/13/24 | PROK | Prokidney Corp. | E9 | Health | BioPrd | Biological Products, (No Diag | Legorreta Pablo G. | NC | DT | P | 54,735 | 2.42 | 0 | 22,618 | New | 22,618 | I | |||||||||||||||
6/28/23 16:01 | 6/28/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Legorreta Pablo G. | NY | DOT | CEO,CB | P | 3,837 | 29.51 | 0 | 130 | 4 | 3,759 | I | ||||||||||||||
6/13/23 16:01 | 6/12/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Legorreta Pablo G. | NY | DOT | CEO,CB | P.m | 2,960 | 32.89 | 0 | 90 | 3 | 3,629 | I | ||||||||||||||
5/24/23 18:45 | 5/24/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Legorreta Pablo G. | NY | DOT | CEO,CB | P | 4,837 | 32.25 | 0 | 150 | 4 | 3,539 | I | ||||||||||||||
5/17/23 18:41 | 5/16/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Legorreta Pablo G. | NY | DOT | CEO,CB | P.m | 7,677 | 33.38 | 0 | 230 | 7 | 3,389 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |